• Biosimilar's Role in Improving Patient Access

  • Feb 27 2024
  • Duración: 43 m
  • Podcast

Biosimilar's Role in Improving Patient Access Por arte de portada

Biosimilar's Role in Improving Patient Access

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Biosimilars are entering the market at their fastest pace ever. In this episode, we interview a renowned health economist and an expert consultant in biosimilar distribution and patient support to explore the complex landscape of biosimilars, including examining the hurdles and breakthroughs in achieving acceptance by payers and providers and how best to improve patient access and affordability in a market dominated by established brands.

    Dr. Jason Shafrin, Senior Managing Director, Center for Healthcare Economics and Policy at FTI Consulting

    Marina Allen, SVP, Fingerpaint Market Access, Patient Support & Access Strategy Leader in Pharma-Biotech

    Biosimilars

    The Biologics Price Competition and Innovation Act of 2009

    PBMs (Pharmacy Benefit Managers)

    Medicare Advantage

    Humira (biosimilars)

    340B program

    Inflation Reduction Act

    Medicare Part D

    "brown bagging and white bagging"

    Mark Cuban (CostPlusDrugs)

    GoodRx

    average sales price (ASP)

    electronic health record (EHR) system

    Questions or comments?
    Email us at comments@prescriptionforbetteraccess.com.
    Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.
    Más Menos
activate_primeday_promo_in_buybox_DT
Enfermedades Físicas Hygiene & Healthy Living Ciencias Biológicas
Más Menos

Lo que los oyentes dicen sobre Biosimilar's Role in Improving Patient Access

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles